ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 70 filers reported holding ANTARES PHARMA INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $852,000 | +5.4% | 207,755 | -8.2% | 0.00% | 0.0% |
| Q4 2021 | $808,000 | -0.1% | 226,229 | +1.8% | 0.00% | 0.0% |
| Q3 2021 | $809,000 | -19.3% | 222,253 | -3.3% | 0.00% | 0.0% |
| Q2 2021 | $1,002,000 | -1.7% | 229,801 | -7.3% | 0.00% | 0.0% |
| Q1 2021 | $1,019,000 | +2.4% | 247,830 | -0.6% | 0.00% | 0.0% |
| Q4 2020 | $995,000 | +47.8% | 249,255 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $673,000 | -1.8% | 249,255 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $685,000 | +20.0% | 249,255 | +3.1% | 0.00% | 0.0% |
| Q1 2020 | $571,000 | -50.5% | 241,875 | -1.5% | 0.00% | -50.0% |
| Q4 2019 | $1,154,000 | +36.9% | 245,532 | -2.6% | 0.00% | 0.0% |
| Q3 2019 | $843,000 | +2.9% | 252,023 | +1.2% | 0.00% | 0.0% |
| Q2 2019 | $819,000 | +22.2% | 249,013 | +12.7% | 0.00% | +100.0% |
| Q1 2019 | $670,000 | +8.9% | 221,042 | -2.3% | 0.00% | 0.0% |
| Q4 2018 | $615,000 | -18.1% | 226,182 | +1.2% | 0.00% | 0.0% |
| Q3 2018 | $751,000 | +31.1% | 223,558 | +0.7% | 0.00% | 0.0% |
| Q2 2018 | $573,000 | +17.2% | 222,098 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $489,000 | +7.7% | 222,098 | -2.6% | 0.00% | 0.0% |
| Q4 2017 | $454,000 | -38.6% | 228,071 | -0.1% | 0.00% | -50.0% |
| Q3 2017 | $740,000 | -9.8% | 228,385 | -10.3% | 0.00% | 0.0% |
| Q2 2017 | $820,000 | +187.7% | 254,600 | -22.3% | 0.00% | +100.0% |
| Q1 2016 | $285,000 | -17.9% | 327,789 | +14.3% | 0.00% | 0.0% |
| Q4 2015 | $347,000 | -27.6% | 286,749 | +1.8% | 0.00% | 0.0% |
| Q3 2015 | $479,000 | -18.5% | 281,633 | -0.4% | 0.00% | 0.0% |
| Q2 2015 | $588,000 | +1.9% | 282,633 | +32.6% | 0.00% | 0.0% |
| Q1 2015 | $577,000 | +3.8% | 213,079 | -1.6% | 0.00% | 0.0% |
| Q4 2014 | $556,000 | +41.1% | 216,479 | +0.4% | 0.00% | 0.0% |
| Q3 2014 | $394,000 | -30.8% | 215,558 | +1.1% | 0.00% | 0.0% |
| Q2 2014 | $569,000 | -20.3% | 213,135 | +4.5% | 0.00% | -50.0% |
| Q1 2014 | $714,000 | -21.9% | 204,035 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $914,000 | +10.9% | 204,035 | +0.5% | 0.00% | 0.0% |
| Q3 2013 | $824,000 | +0.9% | 202,935 | +3.3% | 0.00% | -33.3% |
| Q2 2013 | $817,000 | +23.0% | 196,437 | +5.9% | 0.00% | +50.0% |
| Q1 2013 | $664,000 | – | 185,514 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 1,820,524 | $4,697,000 | 3.00% |
| ARMISTICE CAPITAL, LLC | 12,050,000 | $31,089,000 | 2.03% |
| Broadfin Capital, LLC | 4,623,247 | $11,928,000 | 1.88% |
| Healthcare Value Capital, LLC | 100,000 | $258,000 | 0.73% |
| Healthcare Value Capital, LLC | 100,000 | $258,000 | 0.73% |
| MYCIO WEALTH PARTNERS, LLC | 2,433,500 | $6,278,000 | 0.65% |
| PERKINS CAPITAL MANAGEMENT INC | 317,500 | $819,000 | 0.59% |
| Brown Advisory Securities, LLC | 275,000 | $710,000 | 0.12% |
| FALCON POINT CAPITAL, LLC | 222,501 | $574,000 | 0.11% |
| Avenir Corp | 291,597 | $752,000 | 0.09% |